EXECUTIVE ENGAGEMENTS
POOL
1948
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
351
Interactions with Platform & by Email
PARTICIPANTS
78
Unique # Participated
VALIDATIONS
17
Responses Validated*
COMPANIES
43
Responses Validated*
* Login for a full stack data experience
DATE
JAN 2022
TABLES
123
PAGES
193
EDITION
9
PRICE
USD 4950
CODE
MCP16527
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Label-free Array Systems estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. Surface Plasmon Resonance (SPR), one of the segments analyzed in the report, is projected to record a 5.5% CAGR and reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Bio-layer Interferometry (BLI) segment is readjusted to a revised 4.8% CAGR for the next 7-year period.
The Label-free Array Systems market in the U.S. is estimated at US$375.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$323.5 Million by the year 2027 trailing a CAGR of 5.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.
In the global Cellular Dielectric Spectroscopy (CDS) segment, USA, Canada, Japan, China and Europe will drive the 5.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$58.5 Million in the year 2020 will reach a projected size of US$84.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$204.3 Million by the year 2027.
SELECT PLAYERS
Agilent Technologies, Inc.; Attana AB; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; ForteBio; GWC Technologies; Molecular Devices LLC; PerkinElmer, Inc.; Riot Blockchain, Inc.
SEGMENTS
» Application (Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis, Protein Complex and Cascade Analysis) » End-Use (R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes, Other End-Uses) » Technology (Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS), Quartz Crystal Microbalance)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Label-free Array Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Label-free Array Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Label-free Array Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Surface Plasmon Resonance (SPR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Surface Plasmon Resonance (SPR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Surface Plasmon Resonance (SPR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Bio-layer Interferometry (BLI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Bio-layer Interferometry (BLI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Bio-layer Interferometry (BLI) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Cellular Dielectric Spectroscopy (CDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cellular Dielectric Spectroscopy (CDS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cellular Dielectric Spectroscopy (CDS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Quartz Crystal Microbalance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Quartz Crystal Microbalance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Quartz Crystal Microbalance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Antibody Characterization and Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Antibody Characterization and Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Antibody Characterization and Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Protein Interface Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Protein Interface Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Protein Interface Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Protein Complex and Cascade Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Protein Complex and Cascade Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Protein Complex and Cascade Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for R&D Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Agriculture Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Agriculture Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Agriculture Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Label-free Array Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Label-free Array Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Label-free Array Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Label-free Array Systems by Technology - Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Label-free Array Systems by Technology - Percentage Breakdown of Value Sales for Surface Plasmon Resonance (SPR), Bio-layer Interferometry (BLI), Cellular Dielectric Spectroscopy (CDS) and Quartz Crystal Microbalance for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Label-free Array Systems by Application - Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Label-free Array Systems by Application - Percentage Breakdown of Value Sales for Drug Discovery, Antibody Characterization and Development, Protein Interface Analysis and Protein Complex and Cascade Analysis for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Label-free Array Systems by End-Use - R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Label-free Array Systems by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Contract Research Organizations (CROs), Agriculture Research Institutes and Other End-Uses for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 43 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com